z-logo
open-access-imgOpen Access
Effective Therapy Targeting Cytochrome bc 1 Prevents Babesia Erythrocytic Development and Protects from Lethal Infection
Author(s) -
Joy E. Chiu,
Isaline Renard,
Anasuya Pal,
Pallavi Singh,
Pratap Vydyam,
Jose Thekkiniath,
Madelyn Kumar,
Shalev Gihaz,
Sovitj Pou,
Rolf W. Winter,
Rozalia A. Dodean,
Lisa Frueh,
Aaron Nilsen,
Michael K. Riscoe,
J. Stone Doggett,
Choukri Ben Mamoun
Publication year - 2021
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00662-21
Subject(s) - atovaquone , babesia , babesiosis , biology , virology , malaria , pathogen , outbreak , plasmodium falciparum , cytochrome b , microbiology and biotechnology , immunology , gene , genetics , mitochondrial dna

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom